Chandan Healthcare Ltd

AI
Chandan Healthca Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Chandan Healthcare Ltd

₹ 229 0.22%
21 Oct - close price
chandandiagnostic.com NSE - SME: CHANDAN
About

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]

Key Points

Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points.

Website NSE - SM
  • Market Cap ₹ 560 Cr.
  • Current Price ₹ 229
  • High / Low ₹ 358 / 185
  • Stock P/E 21.3
  • Book Value ₹ 69.9
  • Dividend Yield 0.00 %
  • ROCE 23.3 %
  • ROE 19.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.7%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -2.41%
  • Debtor days have increased from 82.7 to 114 days.
  • Working capital days have increased from 48.3 days to 95.2 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
54.64 62.65 67.90 67.90 65.01 75.58 80.85
45.75 52.41 54.03 53.75 53.17 64.10 61.27
Operating Profit 8.89 10.24 13.87 14.15 11.84 11.48 19.58
OPM % 16.27% 16.34% 20.43% 20.84% 18.21% 15.19% 24.22%
0.17 2.42 0.87 0.84 -1.46 1.85 1.41
Interest 1.09 1.30 1.37 1.40 1.28 1.78 4.83
Depreciation 1.35 2.70 3.75 2.46 2.40 3.74 4.47
Profit before tax 6.62 8.66 9.62 11.13 6.70 7.81 11.69
Tax % 30.21% 29.56% 35.65% 25.79% 24.93% 36.62% 32.34%
4.20 6.02 6.19 7.80 4.54 4.94 7.92
EPS in Rs 2.10 2.46 2.37 3.19 1.86 2.00 3.07
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
120 137 177 230 276 289
117 128 150 190 224 232
Operating Profit 2 9 26 40 53 57
OPM % 1.9% 7% 15% 18% 19% 20%
0 0 1 3 1 3
Interest 2 2 3 5 6 9
Depreciation 2 2 3 7 10 13
Profit before tax -1 5 21 32 38 37
Tax % 3% 28% 24% 27% 25%
-1 3 16 24 29 25
EPS in Rs -0.56 1.68 8.14 9.07 11.07 10.12
Dividend Payout % -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 26%
TTM: 20%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 105%
TTM: 31%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -29%
Return on Equity
10 Years: %
5 Years: 22%
3 Years: 26%
Last Year: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 20 20 20 24 24
Reserves 4 7 21 98 147
17 21 36 48 54
41 49 41 40 65
Total Liabilities 82 98 118 211 290
29 33 48 76 101
CWIP -0 -0 -0 4 12
Investments 6 7 3 33 20
46 58 66 98 156
Total Assets 82 98 118 211 290

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
6 4 1 -3 16
-11 -6 -15 -62 -40
3 2 16 67 21
Net Cash Flow -1 0 2 2 -3
Free Cash Flow -1 -1 -18 -41 -26
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 275% 60% 23% 14% 49%

Ratios

Consolidated / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 88 63 59 75 114
Inventory Days 46 71 96 126 112
Days Payable 185 251 102 103 135
Cash Conversion Cycle -51 -117 53 98 92
Working Capital Days -11 -21 -1 50 95
ROCE % 16% 37% 29% 23%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of Collection Centers
count ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of Diagnostic Centers & Labs
count ・Standalone data
Pathology Revenue Share
%
Total Tests Conducted
Lakhs ・Standalone data
B2C (Retail Diagnostics) Revenue Share
% ・Standalone data
B2G (Government PPPs) Revenue Share
% ・Standalone data
Total Patient Count
Lakhs ・Standalone data
Number of Franchise Centers
count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
49.43% 49.47% 49.47% 49.55% 49.61% 47.20%
3.86% 1.11% 0.00% 0.01% 0.01% 0.00%
6.32% 5.02% 4.76% 5.03% 5.09% 6.49%
40.38% 44.41% 45.78% 45.42% 45.29% 46.32%
No. of Shareholders 8971,3071,4641,6241,5911,685

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls